Search Result "refractory cancer."
Liposomal Irinotecan in the Treatment of Refractory Pancreatic Cancer
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 11 Issue: 4 Year: 2016 Page: 376-383
Author(s): Harold Bien,Gerardo G. Mackenzie,Minsig Choi
Molecular Bases of Liver Cancer Refractoriness to Pharmacological Treatment
Journal: Current Medicinal Chemistry
Volume: 17 Issue: 8 Year: 2010 Page: 709-740
Author(s): J. J.G. Marin, M. R. Romero, O. Briz
Perspectives on mTOR Inhibitors for Castration-Refractory Prostate Cancer
Journal: Current Cancer Drug Targets
Volume: 12 Issue: 8 Year: 2012 Page: 940-949
Author(s): Salvatore L. Burgio,Francesco Fabbri,Ian J. Seymour,Wainer Zoli,Dino Amadori,Ugo De Giorgi
Refractory Chronic Lymphocytic Leukemia: A Therapeutic Challenge
Journal: Current Cancer Drug Targets
Volume: 16 Issue: 8 Year: 2016 Page: 701-709
Author(s): Lukas Smolej
Iodine-Refractory Thyroid Carcinoma
Journal: Reviews on Recent Clinical Trials
Volume: 1 Issue: 2 Year: 2006 Page: 133-141
Author(s): Apar K. Ganti, Ezra E.W. Cohen
The Androgen Receptor as Putative Therapeutic Target in Hormone-Refractory Prostate Cancer
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 2 Issue: 3 Year: 2007 Page: 203-211
Author(s): Yukio Kageyama, Nobuhiko Hyochi, Kazunori Kihara, Hiroshi Sugiyama
The Androgen Receptor as Putative Therapeutic Target in Hormone-Refractory Prostate Cancer
Ebook: Frontiers in Anti-Cancer Drug Discovery
Volume: 1 Year: 2010
Author(s): Yukio Kageyama, Nobuhiko Hyochi, Kazunori Kihara, Hiroshi Sugiyama
Doi: 10.2174/978160805161811001010481
ONCOFID™-P a Hyaluronic Acid Paclitaxel Conjugate for the Treatment of Refractory Bladder Cancer and Peritoneal Carcinosis
Journal: Current Bioactive Compounds
Volume: 7 Issue: 1 Year: 2011 Page: 27-32
Author(s): Monica Campisi, Davide Renier
Cell Dormancy and Tumor Refractory
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13 Issue: 2 Year: 2013 Page: 199-202
Author(s): Yingyan Yu,Zhenggang Zhu
Low Dose Decitabine Combined with Taxol and Platinum Chemotherapy to Treat Refractory/Recurrent Ovarian Cancer: An Open-Label, Single-Arm, Phase I/II Study
Journal: Current Protein & Peptide Science
Volume: 16 Issue: 4 Year: 2015 Page: 329-336
Author(s): Xiaoyu Fu,Yan Zhang,Xiaohui Wang,Meixia Chen,Yao Wang,Jing Nie,Yuanguang Meng,Weidong Han